Drug Target Review – Issue #2 2018

Posted: 31 May 2018 | | No comments yet

In this issue: the positive impact of genomics on drug discovery, development and deployment, the confluence of biology and technology, and Artificial Intelligence: harnessing the potential to drive progress in drug discovery promises much for phenotypic drug discovery

Issue 2 2018 Drug Target Review magazine

Included in this edition:

  • GENOMICS: Genomics in drug development and safety testing; from target identification to genomic toxicology
    Adam David Thomas, University of the West of England
  • SCREENING: Regenerative medicine: enhance cell bioprocessing through cell-based combinatorial culture
    Shahzad Ali, Plasticell Ltd
  • ARTIFICIAL INTELLIGENCE: Adapting drug discovery to Artificial Intelligence
    George Okafo, Vishal Sahni, John Baldoni, Michael Palovich, Ami S Lakdawala and Tobias Sikosek, GSK’s In-silico drug discover unit
  • STEM CELLS: The role of biomaterials in stem cell-based regenerative medicine
    Laura Goldie, Biogelx Ltd
  • IMAGING: Applications of molecular imaging in drug development
    Ben Burke and Stephen Archibald, PET Research Centre, University of Hull


Issue #2 2018 of Drug Target Review is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here